Skip to content

Reprogramming to Prevent Progressive Pacemaker-induced Remodelling

Reprogramming to Prevent Progressive Pacemaker-Induced Remodelling

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03627585
Acronym
PPPR
Enrollment
91
Registered
2018-08-13
Start date
2017-08-01
Completion date
2019-08-06
Last updated
2019-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure, Systolic, Left Ventricular Dysfunction, Left Ventricular Failure, Pacemaker; Complication, Mechanical

Keywords

pacemaker, heart failure, left ventricular dysfunction, bradycardia, remodelling

Brief summary

The aim is to provide evidence of the long-term benefits of personalised pacemaker programming on heart function and battery longevity. This will be achieved by showing in a single centre, phase II, double-blind, randomised, placebo-controlled trial that reducing the amount of pacemaker beats to a minimum reverses these changes and extends battery life.

Detailed description

Patients (n=70) with long-term (\>2 years) permanent pacemakers with avoidable RV pacing will be invited to participate in a single-centre, phase II, randomised, double-blind placebo-controlled trial of optimised pacing programming versus standard care. Those randomised to the intervention arm will have personalised programming to avoid right ventricular pacing, whilst those allocated to standard care will have no programming changes made. All participants will be invited back at 6 months for a repeat echocardiogram, quality of life assessment (EQ-5D-5L), blood tests and pacemaker check.

Interventions

DEVICEPersonalised programming

Reprogramming protocol already test in an observation cohort will be utilised which will direct physiologists to consider pacemaker mode, base rate, utilisation of rate response, hysteresis, sleep and rest rates as well as lead outputs.

Sponsors

University of Leeds
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic right ventricular bradycardia pacemaker implanted for at least 24 months * Willing and able to give informed consent for the intervention

Exclusion criteria

* Known poor imaging quality patients (details of patients excluded for this reason will be recorded) * Patients with complete heart block and no reprogramming options

Design outcomes

Primary

MeasureTime frameDescription
Left ventricular ejection fraction6 monthsLeft ventricular functional measure using either 3D volumes or Simpson's Biplane obtained from echocardiographic images.

Secondary

MeasureTime frameDescription
LV remodelling parameters6 monthsleft ventricular end diastolic and systolic volumes
Quality of Life Measures6 monthsEQ-5D, Minnesota living with Heart Failure Questionnaire
Battery Longevity6 monthsImpedance

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026